Craniopharyngiomas

Endocrinology and Metabolism Clinics of North America

Volumn 37, Issue 1, 2008, Pages 173-193

  Karavitaki, Niki ^a   Wass, John A H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CRANIOPHARYNGIOMA; EPITHELIUM TUMOR; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MORBIDITY; PRIORITY JOURNAL; REVIEW;

ADULT; BRACHYTHERAPY; CHILD; CRANIOPHARYNGIOMA; HUMANS; PITUITARY NEOPLASMS; RADIOSURGERY;

EID: 38349093624     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2007.10.012     Document Type: Review

References (132)

1. Raimondi A.J., and Rougerie J. A critical review of personal experiences with craniopharyngioma: clinical history, surgical technique and operative results. Pediatr Neurosurg 21 (1994) 134-150
2. Saxer F. Ependymepithel, Gliome und epithelische Geschwuelste des Zentralenervensystems. Ziegler's Beitraege 32 (1902) 276
3. Lewis D.D. A contribution to the subject of tumours of the hypophysis. JAMA 55 (1910) 1002-1008
4. Cushing H. The craniopharyngioma. Intracranial tumours (1932), Bailliere, Tindall and Cox, London 93-98
5. Bunin G.R., Surawicz T.S., Witman P.A., et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg 89 (1998) 547-551
6. Parisi J.E., and Mena H. Nonglial tumours. In: Nelson J.S., Parisi J.E., and Schochet Jr. S.S. (Eds). Principles and practice of neuropathology. 1st edition (1993), Mosby, St. Louis (MO) 203-266
7. Matson D.D., and Crigler Jr. J.F. Management of craniopharyngioma in childhood. J Neurosurg 30 (1969) 377-390
8. Schoenberg B.C., Schoenberg D.G., Christine B.W., et al. The epidemiology of primary intracranial neoplasms of childhood. A population study. Mayo Clin Proc 51 (1976) 51-56
9. Kuratsu J., and Ushio Y. Epidemiological study of primary intracranial tumours in childhood. A population-based survey in Kumamoto Prefecture, Japan. Pediatr Neurosurg 25 5 (1996) 240-246
10. DeVile C.J. Craniopharyngioma. In: Wass J.A.H., and Shalet S.M. (Eds). Oxford textbook of endocrinology and diabetes. 1st edition (2002), Oxford University Press, Oxford (UK) 218-225
11. Sorva R., and Heiskanen O. Craniopharyngioma in Finland. A study of 123 cases. Acta Neurochir (Wien) 81 3-4 (1986) 85-89
12. Goldberg G.M., and Eshbaught D.E. Squamous cell nests of the pituitary gland as related to the origin of craniopharyngiomas: a study of their presence in the newborn and infants up to age four. Arch Pathol 70 (1960) 293-299
13. Hunter I.J. Squamous metaplasia of cells of the anterior pituitary gland. J Pathol Bacteriol 69 (1955) 141-145
14. Asa S.L., Kovacs K., and Bilbao J.M. The pars tuberalis of the human pituitary: a histologic, immunohistochemical, ultrastructural and immunoelectron microscopic analysis. Virchows Arch A Pathol Anat Histopathol 399 (1983) 49-59
15. Sarubi J.C., Bei H., Adams F.F., et al. Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes. Neurosci Lett 310 1 (2001) 5-8
16. Gorski G.K., Morro L.E., Donaldson M.H., et al. Multiple chromosomal abnormalities in a case of craniopharyngioma. Cancer Genet Cytogenet 60 2 (1992) 212-213
17. Karnes P.S., Tran T.N., Cui M.Y., et al. Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cytogenet 59 1 (1992) 12-19
18. Rienstein S., Adams E.F., Pilzer D., et al. Comparative genomic hybridization analysis of craniopharyngiomas. J Neurosurg 98 (2003) 162-164
19. Sekine S., Shibata T., Kokubu A., et al. Craniopharyngioma of adamantinomatous type harbor β-catenin gene mutations. Am J Pathol 161 6 (2002) 1997-2001
20. Buslei R., Nolde M., Hofman B., et al. Common mutations of beta-catenin in adamantinomatous but not in other tumours originating from the sellar region. Acta Neuropathol (Berl) 109 (2005) 589-597
21. Hassanein A.M., Glanz S.M., Kessler H.P., et al. Beta-catenin is expressed aberrantly in tumours expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. Am J Clin Pathol 120 5 (2003) 732-736
22. Kato K., Nakataki Y., Kanno H., et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 203 (2004) 814-821
23. Nozaki M., Tada M., and Matsuko R. Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumours of the central nervous system: reappraisal by yeast functional assay. Acta Neuropathol (Berl) 95 (1998) 291-296
24. Kleihnes P., Burger P., and Scheithauer B. Histological typing of tumours of the central nervous system. WHO international histological classification of tumours (1993), Springer-Verlang, Heidelberg (Germany)
25. Nelson G.A., Bastian F.O., Schlitt M., et al. Malignant transformation of craniopharyngioma. Neurosurgery 22 (1988) 427-429
26. Kristopaitis T., Thomas C., Petruzzelli G.J., et al. Malignant craniopharyngioma. Arch Pathol Lab Med 124 (2000) 1356-1360
27. Petito C.K., De Girolami U., and Earle K. Craniopharyngiomas. A clinical and pathological review. Cancer 37 (1976) 1944-1952
28. Crotty T.B., Scheithauer B.W., Young W.F., et al. Papillary craniopharyngioma: a clinico-pathological study of 48 cases. J Neurosurg 83 (1995) 206-214
29. Eldevik O.P., Blaivas M., Gabrielsen T.O., et al. Craniopharyngioma: radiologic and histologic findings and recurrence. AJNR Am J Neuroradiol 17 (1996) 1427-1439
30. Weiner H.L., Wisoff J.H., Rosenberg M.E., et al. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35 6 (1994) 1001-1011
31. Adamson T.E., Wiestler O.D., Kleihues P., et al. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 73 (1990) 12-17
32. Kahn E.A., Gosch H.H., Seeger J.F., et al. Forty-five years experience with the craniopharyngiomas. Surg Neurol 1 (1973) 5-12
33. Gorlin R.J., and Chaudhry A.P. The ameloblastoma and the craniopharyngioma; the similarities and differences. Oral Surg Oral Med Oral Pathol 12 (1959) 199-205
34. Bernstein M.L., and Buchino J.J. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal. Oral Surg Oral Med Oral Pathol 56 (1983) 502-511
35. Banna M. Craniopharyngioma: based on 160 cases. Br J Radiol 49 (1976) 206-223
36. Zhang Y.Q., Wang C.C., and Ma Z.Y. Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatr Neurosurg 36 2 (2002) 80-84
37. Alvarez-Garijo J.A., Froufe A., Taboada D., et al. Successful treatment of an odontogenic ossified craniopharyngioma: case report. J Neurosurg 55 (1981) 832-835
38. Seemayer T.A., Blundell J.S., and Wiglesworth F.W. Pituitary craniopharyngioma with tooth formation. Cancer 29 (1972) 423-430
39. Ghatak N.R., Hirano A., and Zimmerman H.M. Ultrastructure of a craniopharyngioma. Cancer 27 6 (1971) 1465-1475
40. Scheithauer B.W. Region of the sella turcica. In: Burger P.C., Scheithauer B.W., and Vogel F.S. (Eds). Surgical pathology of the nervous system and its coverings. 4th edition (2002), Churchill Livingstone, New York 475-496
41. Miller D.C. Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr Neurosurg 21 Suppl 1 (1994) 11-17
42. Giangaspero F., Burger P.C., Osborne D.R., et al. Suprasellar papillary squamous epithelioma ("papillary craniopharyngioma"). Am J Surg Pathol 8 1 (1984) 57-64
43. Sartoretti-Schefer S., Wichmann W., Aguzzi A., et al. MRI differentiation of adamantinous and squamous-papillary craniopharyngiomas. AJNR Am J Neuroradiol 18 1 (1997) 77-87
44. Xin W., Rubin M.A., and McKeever P.E. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke's cleft cyst. Arch Pathol Lab Med 126 (2002) 174-178
45. Thapar K., Stefaneanu K., Kovacs K., et al. Estrogen receptor gene expression in craniopharyngiomas: an in situ hybridization study. Neurosurgery 35 6 (1994) 1012-1017
46. Honegger J., Renner C., Fahlbush R., et al. Progesterone expression in craniopharyngiomas and evidence for biological activity. Neurosurgery 41 (1997) 1359-1364
47. Izumoto S., Suzuki T., Kinoshita M., et al. Immunohistochemical detection of female sex hormone receptors in craniopharyngiomas: correlation with clinical and histologic features. Surg Neurol 63 (2005) 520-525
48. Ulfarsson E., Karstrom A., Yin S., et al. Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach. Clin Cancer Res 11 (2005) 4674-4680
49. Karavitaki N., Cudlip S., Adams C.B., et al. Craniopharyngiomas. Endocr Rev 27 (2006) 371-397
50. Love J.G., and Marshall T.M. Craniopharyngiomas (pituitary adamantinomas). Surg Gynec Obset 90 (1950) 591-601
51. Banna M., Hoare R.D., Stanley P., et al. Craniopharyngioma in children. J Pediatr 83 5 (1973) 781-785
52. Svolos D.G. Craniopharyngiomas. A study based on 108 verified cases. Acta Chir Scand Suppl 403 (1969) 1-44
53. Fahlbush R., Honegger J., Paulus W., et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90 2 (1999) 237-250
54. Kurosaki M., Saeger W., and Ludecke D.K. Immunohistochemical localisation of cytokeratins in craniopharyngioma. Acta Neurochir (Wien) 143 2 (2001) 147-151
55. Duff J.M., Meyer F.B., Ilstrup D.M., et al. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 46 2 (2000) 291-305
56. Hoffman H.J., DeSilva M., Humphreys R.P., et al. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76 (1992) 47-52
57. Shapiro K., Till K., and Grant D.N. Craniopharyngiomas in childhood. A rational approach to treatment. J Neurosurg 50 (1979) 617-623
58. De Vile C.J., Grant D.B., Kendall B.E., et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?. J Neurosurg 85 (1996) 73-81
59. Yasargil G.M., Curcic M., Kis M., et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73 (1990) 3-11
60. Symon L., Pell M.F., and Habib A.H. Radical excision of craniopharyngioma by the temporal route: a review of 50 patients. Br J Neurosurg 5 (1991) 539-549
61. Karavitaki N., Brufani C., Warner J.T., et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62 (2005) 397-409
62. Costine L.S., Randall S.H., Rubin P., et al. Craniopharyngiomas: fluctuation in cyst size following surgery and radiation therapy. Neurosurgery 24 (1989) 53-59
63. Rajan B., Ashley S., Thomas D.G., et al. Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys 37 (1997) 517-521
64. Barloon T.J., Yuh W.T., Sato Y., et al. Frontal lobe implantation of craniopharyngioma by repeated needle aspiration. AJNR Am J Neuroradiol 9 (1988) 406-407
65. Malik J.M., Cosgrove G.R., and Van der Berg S.R. Remote recurrence of craniopharyngioma in the epidural space. J Neurosurg 77 (1992) 804-807
66. Gupta K., Kuhn M.J., Shevlin D.W., et al. Metastatic craniopharyngioma. Am J Neuroradiol 20 (1999) 1059-1060
67. Ito M., Jamshidi J., and Yamanaka K. Does craniopharyngioma metastasize? Case report and review of the literature. Neurosurgery 48 (2001) 933-936
68. Rajan B., Ashley S., Gorman C., et al. Craniopharyngioma-long-term results following limited surgery and radiotherapy. Radiat Oncol 26 (1993) 1-10
69. Hetelekidis S., Barnes P.D., Tao M.L., et al. 20-Year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27 (1993) 189-195
70. Wen B.C., Hussey D.H., Staples J., et al. A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. Int J Radiat Oncol Biol Phys 16 (1989) 17-24
71. Flickinger J.C., Lunsford L.D., Singer J., et al. Megavoltage external beam irradiation of craniopharyngiomas: analysis of tumour control and morbidity. Int J Radiat Oncol Biol Phys 19 (1990) 177-2
72. Sung D.I., Chang C.H., Harisiadis L., et al. Treatment results of craniopharyngiomas. Cancer 47 (1981) 847-852
73. Regine W.F., and Kramer S. Pediatric craniopharyngiomas: long-term results of combined treatment with surgery and radiation. Int J Radiat Oncol Biol Phys 24 (1992) 611-617
74. Varlotto J.M., Flickinger J.C., Kondziolka D., et al. External beam irradiation of craniopharyngiomas: long-term analysis of tumour control and morbidity. Int J Radiat Oncol Biol Phys 54 (2002) 492-499
75. Hoff J.T., and Patterson R.H. Craniopharyngiomas in children and adults. J Neurosurg 36 (1972) 299-302
76. Pemberton L.S., Dougal M., Magee B., et al. Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol 77 (2005) 99-104
77. Tomita T., and Bowman R.M. Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital. Childs Nerv Syst 21 (2005) 729-746
78. Szeifert G.T., Sipos L., Horvath M., et al. Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases. Acta Neurochir (Wien) 124 (1993) 139-143
79. Nishi T., Kuratsu J., Takeshima H., et al. Prognostic significance of the MIB-1 labeling index for patients with craniopharyngioma. Int J Mol Med 3 (1999) 157-161
80. Duo D., Gasverde S., Benech F., et al. MIB-1 immunoreactivity in craniopharyngiomas: a clinic-pathological analysis. Clin Neuropathol 22 (2003) 229-234
81. Raghavan R., Dickey W.T., Margraf L.R., et al. Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children. Surg Neurol 54 (2000) 241-248
82. Losa M., Vimercati A., Acerno S., et al. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry 75 (2004) 889-892
83. Vidal S., Kovacs K., Lloyd R.V., et al. Angiogenesis in patients with craniopharyngiomas. Correlation with treatment and outcomes. Cancer 94 (2002) 738-745
84. Xu J., Zhang S., You C., et al. Microvascular density and vascular endothelial growth factor have little correlation with prognosis of craniopharyngiomas. Surg Neurol 66 Suppl 1 (2006) S30-S34
85. Lefranc F., Chevalier C., Vinchon M., et al. Characterization of the levels of expression of retinoic acid receptors, galectin-3, macrophage migration inhibiting factor, and p53 in 51 adamantinomatous craniopharyngiomas. J Neurosurg 98 (2003) 145-153
86. Lubansu A., Ruchoux M.-M., Brotchi J., et al. Cathepsin B, D and K expression in adamantinomatous craniopharyngiomas relates to their levels of differentiation as determined by the patterns of retinoic acid receptor expression. Histopathology 43 (2003) 563-572
87. Kalapurakal J.A., Goldman S., Hsieh Y.C., et al. Clinical outcome in children with recurrent craniopharyngioma after primary surgery. Cancer J 6 (2000) 388-393
88. Gutin D.H., Klemme W.M., Lagger R.I., et al. Management of unresectable cystic craniopharyngioma by aspiration through an Ommaya reservoir drainage system. J Neurosurg 52 (1980) 36-40
89. Backlund E.O. Studies on craniopharyngiomas III. Stereotactic treatment with intracystic yttrium-90. Acta Chir Scand 139 (1973) 237-247
90. Pollock B.E., Lunsford L.D., Kondziolka D., et al. Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys 33 (1995) 437-446
91. Voges J., Sturm V., Lehrke R., et al. Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40 (1997) 263-270
92. Bond W.H., Richards D., and Turner E. Experiences with radioactive gold in the treatment of craniopharyngioma. J Neurol Neurosurg Psychiatry 28 (1965) 30-38
93. Van den Berge J.H., Blaauw G., Breeman W.A., et al. Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg 77 (1992) 545-550
94. Hasegawa T., Kondzilka D., Hadjipanayis C.G., et al. Management of cystic craniopharyngiomas with phosphous-32 intracavitary irradiation. Neurosurgery 54 (2004) 813-822
95. 90yttrium. Br J Neurosurg 14 4 (1999) 359-365
96. Takahashi H., Yamaguchi F., and Teramoto F. Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Childs Nerv Syst 21 (2005) 701-704
97. Hader W.J., Steinbok P., Hukin J., et al. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Pediatr Neurosurg 33 (2000) 211-218
98. Frank F., Fabrizi A.P., Frank G., et al. Stereotactic management of craniopharyngiomas. Stereotact Funct Neurosurg 65 (1995) 176-183
99. Caceres A. Intracavitary therapeutic options in the management of cystic craniopharyngioma. Childs Nerv Syst 21 (2005) 705-718
100. Leber K.A., Bergloeff J., and Pendl G. Dose response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88 (1998) 43-50
101. Mokry M. Craniopharyngiomas: a six years experience with gamma knife radiosurgery. Stereotact Funct Neurosurg 72 S1 (1999) 140-149
102. Chung W.Y., Pan D.H., Shiau C.Y., et al. Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg 93 Suppl 3 (2002) 47-56
103. Chiou S.M., Lunsford L.D., Niranjan A., et al. Stereotactic radiosurgery of residual or recurrent craniopharyngioma after surgery with or without radiation therapy. Neuro Oncol 3 (2001) 159-166
104. Kobayashi T., Kida Y., Mori Y., et al. Long-term results of gamma knife surgery for the treatment of craniopharyngiomas in 98 consecutive cases. J Neurosurg 103 6 Suppl (2005) 482-488
105. Yu X., Liu Z., and Li S. Combined treatment with stereotactic intracavitary irradiation and gamma knife surgery for craniopharyngiomas. Stereotact Funct Neurosurg 75 (2000) 117-122
106. Schulz-Ertner D., Frank C., Herfarth K.K., et al. Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 54 (2002) 114-120
107. Minniti G., Saran F., Traish D., et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol 82 (2007) 90-95
108. Ahmed S., Elsheikh M., Stratton I.M., et al. Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50 (1999) 561-567
109. Paja M., Lucas T., Garcia-Uria F., et al. Hypothalamic-pituitary dysfunction in patients with craniopharyngioma. Clin Endocrinol 42 (1995) 467-473
110. Weiss M., Sutton L., Marcial V., et al. The role of radiation therapy in the management of childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 17 6 (1989) 1313-1321
111. Thomsett M.J., Conte F.A., and Kaplan S.L. Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr 97 (1980) 728-735
112. Honegger J., Buchfelder M., and Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 90 (1999) 251-257
113. Zahmann M., and Illig R. Precocious puberty after surgery for craniopharyngioma. J Pediatr 95 (1979) 86-88
114. Cabezudo J.M., Perez C., Vaquero J., et al. Pubertas praecox in craniopharyngioma. J Neurosurg 55 (1981) 127-131
115. Geffner M.E. The growth without growth hormone syndrome. Endocrinol Metab Clin North Am 25 3 (1996) 649-663
116. Verhelst J., Kendal-Taylor P., Erfurth E.M., et al. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngiomas in comparison with patients with non-functioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). J Clin Endocrinol Metab 90 (2005) 4636-4643
117. Price D.A., Wilton P., Jonsson P., et al. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 49 (1998) 91-97
118. Abs R., Bengtsson B.-A., Hernberg-Stahl E., et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol 50 (1999) 703-713
119. Karavitaki N., Warner J.T., Marland A., et al. GH replacement does not increase the risk of recurrence in patients with craniopharyngiomas. Clin Endocrinol 64 5 (2006) 556-560
120. Darendeliler F., Karagiannis G., Wilton P., et al. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr 95 (2006) 1284-1290
121. Abrams L.S., and Repka M.X. Visual outcome of craniopharyngioma in children. J Pediatr Ophthalmol Strabismus 34 4 (1997) 223-224
122. Cabezudo Artero J.M., Vaquero Crespo J., and Bravo Zabalgoitia G. Status of vision following surgical treatment of craniopharyngiomas. Acta Neurochir (Wien) 73 (1984) 165-177
123. Harris J.R., and Levene M.B. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology 120 (1976) 167-171
124. De Vile C.J., Grant D.B., Hayward R.D., et al. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 75 (1996) 108-114
125. Smith D., Finucane F., Phillips J., et al. Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma. Clin Endocrinol 61 (2004) 273-279
126. Pereira A.M., Scmid E.M., Schutte P.J., et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngiomas. Clin Endocrinol 62 (2005) 197-204
127. Bulow B., Attewell R., Hagmar L., et al. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumour recurrence. J Clin Endocrinol Metab 83 (1998) 3897-3904
128. Van Effenterre R., and Boch A.L. Craniopharyngioma in adults and children. J Neurosurg 97 (2002) 3-11
129. Stripp D.C., Maity A., Janss A.J., et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 58 (2004) 714-720
130. Tomlinson J.W., Holden N., Hills R.K., et al. Association between premature mortality and hypopituitarism. Lancet 357 (2001) 425-431
131. Lyen K.R., and Grant D.B. Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 57 (1982) 837-841
132. Tarbell N.J., Barnes P., Scott R.M., et al. Advances in radiation therapy for craniopharyngiomas. Pediatr Neurosurg 21 Suppl 1 (1994) 101-107